STEVANATO GROUP AND SHL MEDICAL PROVIDE A COMPATIBLE CONTAINER-DEVICE PLATFORM THAT MAINTAINS CAP AND NEEDLE-SHIELD REMOVAL FORCES WITHIN A RANGE THAT ENSURES CLOSURE INTEGRITY BUT REMAINS OPERABLE WITHOUT EXCESSIVE PATIENT EFFORT. Stevanato Group and SHL Medical provide a compatible container-device platform that maintains cap and needle-shield removal forces within a range that ensures closure integrity but remains operable without excessive patient effort
Early evaluation allows doctors to adjust treatment, switch medications, or discuss other weight-loss options such as endoscopic procedures
Diabetes 60(12):31033109 Yanagimachi T, Fujita Y, Takeda Y et al (2016) Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (130) expression is upregulated in diabetes and PEGylated GIP(130) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice
Step 5: Hold for the full duration This is the most critical step
Data collection process For each included trial, we used predesigned forms to extract study characteristics, participants demographics and baseline characteristics, and outcome data
Showering is fine immediately after injection